Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite,population-based surveillance |
| |
| Institution: | 1. National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA;2. Department of Preventive Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA;3. Minnesota Department of Health, St Paul, MN, USA;4. Department of Medicine, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA;5. Connecticut Department of Public Health, Hartford, CT, USA;6. New York State Department of Health, Albany, NY, USA;7. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;8. California Emerging Infections Program, Oakland, CA, USA;9. School of Public Health, Department of Epidemiology, University of California, Berkeley, CA, USA;10. Colorado Department of Public Health and Environment, Denver, CO, USA;11. Institute for Public Health, University of New Mexico, Emerging Infections Program, Albuquerque, NM, USA;12. Oregon Public Health Division and Oregon Emerging Infections Program, Portland, OR, USA;13. Division of Infectious Diseases, Emory University School of Medicine, Atlanta, GA, USA;14. Infection Disease Section, Medical Specialty Care Service Line, Atlanta VA Medical Center, Atlanta, GA, USA;15. Stat-Epi Associates, Ponte Vedra Beach, FL, USA;p. Department of Pathology, University of Texas Health Science Center, San Antonio, TX, USA;1. Division of Pediatric Infectious Diseases, Department of Pediatrics, University of Utah School of Medicine, Salt Lake City, UT, USA;2. Department of Pharmacology and Toxicology, University of Utah College of Pharmacy, Salt Lake City, UT, USA;1. Sage Analytica, Bethesda, MD, USA;2. Department of Global Health, School of Public Health and Health Services, George Washington University, Washington DC, USA;3. Rollins School of Public Health, Atlanta, GA, USA;1. Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya;2. Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA;3. Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK;4. Kenya Ministry of Health, Kilifi, Kenya;5. Kenya Ministry of Health, Nairobi, Kenya;6. London School of Hygiene & Tropical Medicine, London, UK;1. Department of Public Health Solutions, National Institute for Health and Welfare, P.O. Box 30, FI-00271 Helsinki, Finland;2. Department of Public Health Solutions, National Institute for Health and Welfare, Biokatu 10, FI-33520 Tampere, Finland;3. Department of Mathematics and Statistics, University of Turku, 20014 Turun yliopisto, Turku, Finland;4. Department of Health Security, National Institute for Health and Welfare, P.O. Box 30, FI-00271 Helsinki, Finland;5. Department of Epidemiology, School of Health Sciences, University of Tampere, Kalevantie 4, FI-33014 Tampere, Finland;1. Département des maladies infectieuses, Institut de Veille Sanitaire, Saint Maurice, France;2. Centre National de Référence des Pneumocoques, AP-HP, Hôpital Européen Georges Pompidou, Paris, France;3. Université Paris Sud, EA 4043 Châtenay-Malabry, France;1. Faculdade de Medicina da Universidade Metropolitana de Santos, São Paulo, Brazil;2. Faculdade de Ciências Médicas da Santa Casa de São Paulo, São Paulo, Brazil;3. Hospital Nacional de Niños Dr. Carlos Sáenz Herrera, San José, Costa Rica;4. Facultad de Medicina, Universidad de la República, Uruguay;5. Hospital de Niños Ricardo Gutierrez, Ciudad Autónoma de Buenos Aires, Argentina;6. Secretaría de Salud del Estado de Morelos, Mexico;7. Centro Medico Universidad Central Del Este, Santo Domingo, Dominican Republic;8. Universidad Militar Nueva Granada, Bogotá, Colombia |
| |
| Abstract: | |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
